Agitation is one of the most common symptoms of Alzheimer’s disease, leading patients to become restless or even verbally and physically aggressive. The FDA has approved the first drug to treat these behavioral symptoms.
The Thursday approval of the drug, brexpiprazole (brand name Rexulti),…
Source: medcitynews.com – Read more
Climate Change Taking Toll on Workers’ Health – Report – Healthcare Asia Daily News | Asia’s Leading News and Information Source on Healthcare and Medical Industry, Medical Technology, Healthcare Business and R&D, Healthcare Events. Online since 2010 : Healthcare Asia Daily News
A new report reveals that climate change is adversely impacting workers’ health, according to Healthcare Asia Daily News. It appears that rising global temperatures are
